These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 2457077

  • 1. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
    DeLander GE, Wahl JJ.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):565-70. PubMed ID: 2457077
    [Abstract] [Full Text] [Related]

  • 2. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
    DeLander GE, Wahl JJ.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of nociception evoked by intrathecal high-dose morphine.
    Sakurada T, Komatsu T, Sakurada S.
    Neurotoxicology; 2005 Oct; 26(5):801-9. PubMed ID: 15936820
    [Abstract] [Full Text] [Related]

  • 7. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord.
    Hornfeldt CS, Larson AA.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1064-8. PubMed ID: 2574739
    [Abstract] [Full Text] [Related]

  • 8. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE, Wahl JJ.
    Eur J Pharmacol; 1989 Jan 10; 159(2):149-56. PubMed ID: 2468511
    [Abstract] [Full Text] [Related]

  • 9. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM, Tibola D, Paszcuk AF, Rodrigues AL, Calixto JB, Santos AR.
    Brain Res; 2006 Jun 06; 1093(1):116-22. PubMed ID: 16765330
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C, Orito T, Watanabe H, Mizoguchi H, Yonezawa A, Yanai K, Mobarakeh JI, Onodera K, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):54-63. PubMed ID: 18155693
    [Abstract] [Full Text] [Related]

  • 16. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission.
    Keil GJ, DeLander GE.
    Eur J Pharmacol; 1996 Sep 19; 312(1):7-14. PubMed ID: 8891573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats.
    Sjölund KF, Sollevi A, Segerdahl M, Lundeberg T.
    Anesth Analg; 1997 Sep 19; 85(3):627-32. PubMed ID: 9296420
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.